TCL Archive Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards February 7, 1997
TCL Archive NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions. December 12, 2003